Grid of patient photos with a blue background

Press

The Virta Treatment reverses type 2 diabetes and other chronic metabolic diseases, safely and sustainably, without the risks, costs, or side effects of medications or surgery. Our mission is to reverse type 2 diabetes in 100 million people by 2025.

For press inquiries and interview requests, feel free to contact us at any time at press@virtahealth.com

Virta Brand Assets

Download our press kit for the latest logos, product screenshots and company photos.

Download Virta brand assets

As Featured In

Forbes logoFortuneThe New York Times logoNewsweek logoTechCrunch logoLogo: Business Insider
“Virta gives diabetics a cross between a pocket doctor and a guardian angel.”

Newsweek, How Artificial Intelligence Will Cure America's Sick Health Care System

“Virta’s virtual clinic can fill a gap between visits, which is important for people who are dealing with their diseases every day and need additional support.”

STAT, 5 burning questions about digital health and chronic disease management

“It's a much more scalable model than seeing people in a doctor's office.”

The New York Times, Tackling Weight Loss and Diabetes With Video Chats

“…Virta Health, is taking a more daring approach, which it hopes will ultimately eliminate the type 2 diabetes altogether.”

CNBC, This woman tattooed the logo of diabetes management start-up Virta Health on her arm to remind her to stick with the program

“Virta's value-based approach to reimbursement and the oppressive costs of diabetes treatment are helping the company acquire large payer partners.”

Business Insider, Virta Health and Blue Shield of California are teaming up on diabetes treatment

About Virta

2014

Founded

$166M

Raised through Series C

50

States where Virta is available

Diabetes Trends (US)

30M

People living with type 2 diabetes

86M

People living with prediabetes

$404B

Economic burden of diabetes

Virta's Clinical Trial

60%

Diabetes reversal rate* at 1 year¹

94%

Patients who reduced or eliminated insulin at 1 year¹

$9,565

Estimated savings per patient for the first two years²

Brand Assets

A grid of headshots of Virta leadership

Virta Leadership

Download photos
Neha, Virta patient

Virta Patients & Providers

Download photos

Citations and Footnotes

  1. Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9. Reversal rate refers to % of patients with HbA1c less than 6.5% who are taking no diabetes-specific medications.
  2. Note: does not include consideration of Virta fees. Source: Virta internal analysis - Economic Impact Model built using Virta clinical results and published estimates of medical & pharmacy costs by A1c level and BMI from Li et. al., The Economic Burden of Obesity by Glycemic Stage in the United States; PharmacoEconomics (2015) 33:735–748.